The chromatin remodeler ADNP regulates neurodevelopmental disorder risk genes and neocortical neurogenesis
Abstract
Although chromatin remodelers are among the most important risk genes associated with neurodevelopmental disorders (NDDs), the roles of these complexes during brain development are in many cases unclear. Here, we focused on the recently discovered ChAHP chromatin remodeling complex. The zinc finger and homeodomain transcription factor ADNP is a core subunit of this complex, and de novo ADNP mutations lead to intellectual disability and autism spectrum disorder. However, germline Adnp knockout mice were previously shown to exhibit early embryonic lethality, obscuring subsequent roles for the ChAHP complex in neurogenesis. To circumvent this early developmental arrest, we generated a conditional Adnp mutant allele. Using single-cell transcriptomics, cut&run-seq, and histological approaches, we show that during neocortical development, Adnp orchestrates the production of late-born, upper-layer neurons through a two-step process. First, Adnp is required to sustain progenitor proliferation specifically during the developmental window for upper-layer cortical neurogenesis. Accordingly, we found that Adnp recruits the ChAHP subunit Chd4 to genes associated with progenitor proliferation. Second, in postmitotic differentiated neurons, we define a network of risk genes linked to NDDs that are regulated by Adnp and Chd4. Taken together, these data demonstrate that ChAHP is critical for driving the expansion of upper-layer cortical neurons and for regulating neuronal gene expression programs, suggesting that these processes may potentially contribute to NDD etiology.
Article Details
Journal Info
Proceedings of the National Academy of Sciences
National Academy of Sciences
Authors (11)
Samuel Clémot-Dupont
Regenerative Medicine Program, Ottawa Hospital Research Institute
José Alex Lourenço Fernandes
Regenerative Medicine Program, Ottawa Hospital Research Institute
Sarah Larrigan
Regenerative Medicine Program, Ottawa Hospital Research Institute
Xiaoqi Sun
Department of Chemistry, College of Science
Suma Medisetti
Regenerative Medicine Program, Ottawa Hospital Research Institute
Rory Stanley
Regenerative Medicine Program, Ottawa Hospital Research Institute
Ziyad El Hankouri
Regenerative Medicine Program, Ottawa Hospital Research Institute
Shrilaxmi V. Joshi
Regenerative Medicine Program, Ottawa Hospital Research Institute
David J. Picketts
Regenerative Medicine Program, Ottawa Hospital Research Institute
Karthik Shekhar
Department of Chemical and Biomolecular Engineering, University of California
Pierre Mattar
Regenerative Medicine Program, Ottawa Hospital Research Institute